New Vaccine Safety Study Could Answer Lingering Questions
A Kaiser Permanente researcher says her large-scale four-year study in the Portland and Seattle areas will help track a virus that’s still evolving.
A Kaiser Permanente researcher says her large-scale four-year study in the Portland and Seattle areas will help track a virus that’s still evolving.
Federal health advisors last week authorized COVID-19 vaccines for children as young as six months old, the last age group to gain access to the vaccine.
The Novavax vaccine appears to cause fewer unpleasant reactions — fever, chills, and exhaustion — associated with mRNA vaccines produced by Moderna and Pfizer-BioNTech.
Most states lag Oregon as a third of older people nationwide haven't received their first COVID vaccine booster shot.
When Albert Bourla said all Americans will need a second booster shot, some experts saw his claim as self-serving.
The husband of an Oregon woman who died of a rare J&J vaccine side effect questions whether authorities have done enough to educate the public.
Nearly 17 million U.S. residents who received the Johnson & Johnson vaccine now face a quandary: Should they get another shot?
A year ago, there was little to no vaccine safety data for pregnant people, leaving health experts divided about how to advise expectant parents.
After eligible people were being turned away from pharmacies, the health agency reiterated its recommendation.
With scientists still gathering information about omicron, authorities say the main way to prepare is to get vaccinated for COVID-19.